The intraductal component of breast cancer is poorly responsive to neo-adjuvant chemotherapy.

Wu, Wenwen

The intraductal component of breast cancer is poorly responsive to neo-adjuvant chemotherapy. [electronic resource] - Oncology reports - 1027-31 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1021-335X


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Apoptosis
Breast Neoplasms--drug therapy
Carcinoma, Intraductal, Noninfiltrating--drug therapy
Cell Division
Chemotherapy, Adjuvant
Cyclophosphamide--administration & dosage
Docetaxel
Doxorubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Immunohistochemistry
In Situ Nick-End Labeling
Ki-67 Antigen--biosynthesis
Middle Aged
Paclitaxel--administration & dosage
Taxoids
Treatment Outcome